ArticleFrontiers in oncology2022

Treatment-Free Remission in Chronic Myeloid Leukemia Patients Treated With Low-Dose TKIs: A Feasible Option Also in the Real-Life. A Campus CML Study.

Alessandra Iurlo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.